Search all medical codes
Tetanus and diphtheria toxoids (Td) adsorbed when administered to individuals 7 years or older, for intramuscular use
CPT4 code
Name of the Procedure:
Tetanus and Diphtheria Toxoids (Td) Adsorbed
Commonly referred to as the Td vaccine.
Summary
The Td vaccine is an injection given to individuals aged 7 years or older to protect against tetanus and diphtheria. It is administered intramuscularly, typically in the upper arm.
Purpose
The Td vaccine helps prevent tetanus (lockjaw), a condition that causes severe muscle stiffness and spasms, and diphtheria, a serious respiratory illness that can cause breathing problems, heart failure, paralysis, or death.
Indications
- Individuals who have not completed their primary vaccination series against tetanus and diphtheria.
- Adults requiring booster vaccinations every 10 years.
- Children aged 7 years or older transitioning from pediatric to adult vaccination schedules.
- People at risk of exposure to these diseases due to injury or wound.
Preparation
- No specific dietary restrictions or fasting required.
- Inform your healthcare provider about any current medications, allergies, or past adverse reactions to vaccines.
- A brief health assessment may be conducted to ensure suitability for the vaccine.
Procedure Description
- The patient will sit or lie down.
- The healthcare provider will clean the injection site, usually the upper arm, with an antiseptic wipe.
- The Td vaccine is drawn into a sterile syringe.
- The vaccine is injected into the muscle of the upper arm using the syringe.
- The site is then pressed with a cotton ball or bandage to prevent bleeding.
Duration
The entire process usually takes about 5-10 minutes.
Setting
The Td vaccination is typically performed in an outpatient clinic, doctor's office, or healthcare facility.
Personnel
- A trained nurse or healthcare provider administers the injection.
- A physician or nurse practitioner may supervise.
Risks and Complications
- Common risks: soreness at the injection site, mild fever, fatigue.
- Rare risks: allergic reactions, severe pain, or muscle weakness at the injection site.
- Management includes over-the-counter pain relievers and consulting a healthcare provider if severe reactions occur.
Benefits
- Long-term protection against tetanus and diphtheria.
- The benefits usually start to be effective within a few weeks after the injection.
Recovery
- Few minutes of observation post-injection to monitor for immediate reactions.
- Normal activities can typically be resumed immediately.
- Minor pain or swelling at the injection site can be managed with pain relievers and cold compresses.
- Follow-up booster doses are recommended every 10 years.
Alternatives
- Combined Tetanus, Diphtheria, and Pertussis (Tdap) vaccine, which also includes protection against pertussis (whooping cough).
- Pros: Tdap provides additional protection against an extra infectious disease.
- Cons: More components may result in more side effects.
Patient Experience
- During the injection, a minor pinch or brief discomfort may be felt.
- After the procedure, some patients may experience mild soreness or swelling at the injection site, which usually subsides within a few days.
- Pain management includes over-the-counter analgesics and keeping the injection site clean and dry.